Nerveli has built a mobile application that begins with a video-guided sensory test and interactive surveys to assess each user’s pain profile, then delivers personalized coaching and daily exercises rooted in cognitive behavioral therapy. The platform combines artificial intelligence, exclusive IP licensed from Harvard-affiliated pain psychologist Dr. Desiree Azizoddin, and a proprietary body pain assessment tool for which the company has filed a provisional patent. Its founding team blends pain psychologists, physicians, data scientists, and technologists, including senior advisor Dr. Ted Price of UT Dallas. Nerveli plans to sell its solution on a B2B SaaS basis to employers, payers, providers, health systems, and personal-injury attorneys, with first pilots slated for October at a back-pain institute and an employer partner. The company estimates a $250 billion total addressable market for chronic pain and a $250 million serviceable obtainable market. Financially, Nerveli has secured an oversubscribed $540,000 pre-seed round and previously received $120,000 from the Techstars Physical Health Fort Worth Accelerator, placing total external funding at $660,000 to date. The new capital will fund completion of its full patent application and support upcoming pilot deployments as it seeks to become the trusted name in digital pain recovery.

Total raised

$1M

Funding rounds

1

Latest round

Seed

Latest activity

Oct 2025